ARCHIVES

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

This article is from The Cancer Letter archive.

Vol. 06 No. 47 | November 28, 1980

Download PDF Visit The Full Archive

Related Articles

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007